Suppr超能文献

3.0和7.0T下无几何畸变的扩散敏感型眼科磁共振成像:健康受试者和眼内肿块患者的可行性研究

Diffusion-sensitized ophthalmic magnetic resonance imaging free of geometric distortion at 3.0 and 7.0 T: a feasibility study in healthy subjects and patients with intraocular masses.

作者信息

Paul Katharina, Graessl Andreas, Rieger Jan, Lysiak Darius, Huelnhagen Till, Winter Lukas, Heidemann Robin, Lindner Tobias, Hadlich Stefan, Zimpfer Annette, Pohlmann Andreas, Endemann Beate, Krüger Paul-Christian, Langner Sönke, Stachs Oliver, Niendorf Thoralf

机构信息

From the *Berlin Ultrahigh Field Facility (BUFF), Max-Delbrueck-Center for Molecular Medicine, Berlin; †MRI.TOOLS GmbH, Berlin; ‡Siemens Healthcare Sector, Erlangen; §Preclinical Imaging Research Group, University Medicine Rostock, Rostock; ∥Institute for Diagnostic Radiology and Neuroradiology, University of Greifswald, Greifswald; ¶Institute of Pathology, University Medicine Rostock, Rostock; #Department of Ophthalmology, University Medicine Rostock, Rostock; and **Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.

出版信息

Invest Radiol. 2015 May;50(5):309-21. doi: 10.1097/RLI.0000000000000129.

Abstract

OBJECTIVES

This study is designed to examine the feasibility of diffusion-sensitized multishot split-echo rapid acquisition with relaxation enhancement (RARE) for diffusion-weighted ophthalmic imaging free of geometric distortions at 3.0 and 7.0 T in healthy volunteers and patients with intraocular masses.

MATERIALS AND METHODS

A diffusion-sensitized multishot split-echo RARE (ms-RARE) variant is proposed as an alternative imaging strategy for diffusion-weighted imaging. It is compared with standard single-shot echo planar imaging (EPI) and readout-segmented EPI in terms of geometric distortions in a structure phantom as well as in vivo at 3.0 and 7.0 T. To quantify geometric distortions, center of gravity analysis was carried out. Apparent diffusion coefficient (ADC) mapping in a diffusion phantom was performed to verify the diffusion sensitization within ms-RARE. An in vivo feasibility study in healthy volunteers (n = 10; mean age, 31 ± 7 years; mean body mass index, 22.6 ± 1.7 kg/m²) was conducted at 3.0 and 7.0 T to evaluate clinical feasibility of ms-RARE. As a precursor to a broader clinical study, patients (n = 6; mean age, 55 ± 12 years; mean body mass index, 27.5 ± 4.7 kg/m²) with an uveal melanoma and/or retinal detachment were examined at 3.0 and 7.0 T. In 1 case, the diseased eye was enucleated as part of the therapy and imaged afterward with magnetic resonance microscopy at 9.4 T. Macrophotography and histological investigation was carried out. For qualitative assessment of the image distortion, 3 independent readers reviewed and scored ms-RARE in vivo images for all subjects in a blinded reading session. Statistical significance in the difference of the scores (a) obtained for the pooled ms-RARE data with b = 0 and 300 s/mm² and (b) for the 3 readers was analyzed using the nonparametric Mann-Whitney test.

RESULTS

The assessment of geometric integrity in phantom imaging revealed the ability of ms-RARE to produce distortion-free images. Unlike ms-RARE, modest displacements (2.3 ± 1.4 pixels) from the fast low angle shot imaging reference were observed for readout-segmented EPI, which were aggravated for single-shot EPI (8.3 ± 5.7 pixels). These observations were confirmed in the in vivo feasibility study including distortion-free diffusion-weighted ophthalmic images with a 0.5 × 0.5 × 5 mm³ spatial resolution at 3.0 T and as good as 0.2 × 0.2 × 2 mm³ at 7.0 T. The latter represents a factor of 40 enhancement in spatial resolution versus clinical protocols recently reported for diffusion-weighted imaging of the eye at 1.5 T. Mean ADC values within the vitreous body were (2.91 ± 0.14) × 10⁻³ mm²/s at 3.0 T and (2.93 ± 0.41) × 10⁻³ mm²/s at 7.0 T. Patient data showed severe retinal detachment in the anatomical images. Whereas the tumor remained undetected in T1-weighted and T2-weighted imaging at 3.0/7.0 T, in vivo ADC mapping using ms-RARE revealed the presence of a uveal melanoma with a significant contrast versus the surrounding subretinal hemorrhage. This observation was confirmed by high-resolution ex vivo magnetic resonance microscopy and histology. Qualitative analysis of image distortion in ms-RARE images obtained for all subjects yielded a mean ± SD image quality score of 1.06 ± 0.25 for b = 0 s/mm² and of 1.17 ± 0.49 for b = 300 s/mm². No significant interreader differences were observed for ms-RARE with a diffusion sensitization of b = 0 s/mm² and 300 s/mm².

CONCLUSIONS

This work demonstrates the capability of diffusion-sensitized ms-RARE to acquire high-contrast, high-spatial resolution, distortion-free images of the eye and the orbit at 3.0 and 7.0 T. Geometric distortions that are observed for EPI-based imaging approaches even at lower field strengths are offset by fast spin-echo-based imaging techniques. The benefits of this improvement can be translated into the assessment of spatial arrangements of the eye segments and their masses with the ultimate goal to provide guidance during diagnostic treatment of ophthalmological diseases.

摘要

目的

本研究旨在探讨在3.0T和7.0T场强下,扩散敏感型多激发分割回波快速采集弛豫增强(RARE)序列用于无几何变形的扩散加权眼部成像的可行性,研究对象包括健康志愿者和眼内肿物患者。

材料与方法

提出一种扩散敏感型多激发分割回波RARE(ms-RARE)变体作为扩散加权成像的替代成像策略。在体模以及3.0T和7.0T场强下的活体中,将其与标准单激发回波平面成像(EPI)和读出分段EPI在几何变形方面进行比较。为量化几何变形,进行了重心分析。在扩散体模中进行表观扩散系数(ADC)映射,以验证ms-RARE序列内的扩散敏感性。在3.0T和7.0T场强下对10名健康志愿者(平均年龄31±7岁;平均体重指数22.6±1.7kg/m²)进行了活体可行性研究,以评估ms-RARE序列的临床可行性。作为更广泛临床研究的前期准备,对6名患有葡萄膜黑色素瘤和/或视网膜脱离的患者(平均年龄55±12岁;平均体重指数27.5±4.7kg/m²)在3.0T和7.0T场强下进行了检查。其中1例患者的患眼在治疗过程中被摘除,随后用9.4T的磁共振显微镜进行成像,并进行了大体摄影和组织学检查。为定性评估图像变形,3名独立阅片者在盲法阅片过程中对所有受试者的ms-RARE活体图像进行了评估和评分。使用非参数曼-惠特尼检验分析(a)b = 0和300s/mm²时合并的ms-RARE数据得分以及(b)3名阅片者得分的差异的统计学意义。

结果

体模成像中的几何完整性评估显示,ms-RARE序列能够生成无变形图像。与ms-RARE序列不同,读出分段EPI相对于快速低角度激发成像参考有适度位移(2.3±1.4像素),单激发EPI的位移更严重(8.3±5.7像素)。这些观察结果在活体可行性研究中得到证实,包括在3.0T场强下具有0.5×0.5×5mm³空间分辨率以及在7.0T场强下高达0.2×0.2×2mm³的无变形扩散加权眼部图像。与最近报道的1.5T场强下眼部扩散加权成像的临床方案相比,后者的空间分辨率提高了40倍。玻璃体中的平均ADC值在3.0T时为(2.91±0.14)×10⁻³mm²/s,在7.0T时为(2.93±0.41)×10⁻³mm²/s。患者数据显示解剖图像中有严重的视网膜脱离。在3. /7.0T的T1加权和T2加权成像中未检测到肿瘤,而使用ms-RARE序列进行的活体ADC映射显示存在葡萄膜黑色素瘤,与周围视网膜下出血有明显对比。这一观察结果通过高分辨率离体磁共振显微镜和组织学得到证实。对所有受试者的ms-RARE图像进行的图像变形定性分析显示,b = 0s/mm²时的平均±标准差图像质量评分为1.06±0.25,b = 300s/mm²时为1.17±0.49。对于b = 0s/mm²和300s/mm²的扩散敏感性,ms-RARE序列在阅片者之间未观察到显著差异。

结论

本研究表明,扩散敏感型ms-RARE序列能够在3.0T和7.0T场强下获取眼部和眼眶的高对比度、高空间分辨率、无变形图像。基于EPI的成像方法即使在较低场强下观察到的几何变形,也能被基于快速自旋回波的成像技术抵消。这种改进的益处可转化为对眼段及其肿物空间排列的评估,最终目标是为眼科疾病的诊断治疗提供指导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验